Prenatal, early life, and childhood exposure to genotoxicants in the living environment

Arhiv za Higijenu Rada i Toksikologiju

Volumn 61, Issue 4, 2010, Pages 455-464

  Katić, Jelena ^a   Fučić, Aleksandra ^a   Gamulin, Marija ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

child genotoxicology; environmental exposure; genome damage; transplacental genotoxicology; xenobiotics

Indexed keywords

ARSENIC; ASBESTOS; CADMIUM; NICKEL; NITRATE; TOBACCO SMOKE;

CANCER PREVENTION; CANCER RISK; EARLY LIFE STRESS; ENVIRONMENTAL EXPOSURE; FOOD POISONING; GENOTOXICITY; HUMAN; IONIZING RADIATION; PRENATAL DRUG EXPOSURE; RADIOACTIVITY; REVIEW;

AIR POLLUTANTS; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FOOD CONTAMINATION; FOOD CONTAMINATION, RADIOACTIVE; HUMANS; INFANT; MUTAGENS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; WATER POLLUTANTS, CHEMICAL; XENOBIOTICS;

NICOTIANA TABACUM;

EID: 78650643422     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-61-2010-2065     Document Type: Review

References (112)

1. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, Parkin M. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004;364:2097-105.
2. Grandjean P, Bellinger D, Bergman A, Cordier S, Davey-Smith G, Eskenazi B, Gee D, Gray K, Hanson M. The Faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol 2008;102:73-5.
3. Carlsen KH. Astma - en tilstand for vår tid, en tilstand i forandring [Asthma - a condition of our time, a condition in change in Norwegian]. Tidsskr Nor Laegeforen 2001;121:836-40.
4. Mongraw-Chaffin ML, Cohn BA, Anglemyer AT, Cohen RD, Christianson RE. Maternal smoking, alcohol, and coffee use during pregnancy and son's risk of testicular cancer. Alcohol 2009;43:241-5.
5. Lis, Hursting SD, Davis BJ, McLachlan JA, Barrett JC. Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann NY Acad Sci 2003;983:161-9.
6. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
7. Toyokunis. Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics. IUBMB Life 2008;60:441-7.
8. Mikhailov VF, Mazurik VK, Burlakova EB. [Signal function of the reactive oxygen species in regulatory networks of the cell reaction to damaging effects: contribution of radiosensitivity and genome instability, in Russian]. Radiat Biol Radioecol 2003;43:5-18.
9. Ilnytskyy Y, Koturbash I, Kovalchuk O. Radiation-induced bystander effects in vivo are epigenetically regulated in a tissue-specific manner. Environ Mol Mutagen 2009;50:105-13.
10. Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J, Brooks S. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7.
11. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma - a possible risk. Mol Cell Endocrinol 2003;202:109-16.
12. Konduris, Schwarz RE. Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. J Surg Res 2007;140:55-66.
13. Wang SL, Chang YC, Chao HR, Li CM, LilA, Lin LY, Papke O. Body burdens of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls and their relations to estrogen metabolism in pregnant women. Environ Health Perspect 2006;114:740-5.
14. Bennion BJ, Cosman M, Lightstone FC, Knize MG, Montgomery JL, Bennett LM, Felton JS, Kulp KS. PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor. Chem Res Toxicol 2005;18:1528-36.
15. Stefanidou M, Maravelias C, Spiliopoulou C. Human exposure to endocrine disruptors and breast milk. Endocr Metab Immune Disord Drug Targets 2009;9:269-76.
16. Turner KJ, Sharpe RM. Environmental oestrogens - present understanding. Rev Reprod 1997;2:69-73.
17. Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 1986;77:1727-33.
18. Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 2003;111:389-94.
19. Rosenthal MD, Albrecht ED, Pepe GJ. Estrogen modulates developmentally regulated gene expression in the fetal baboon liver. Endocrine 2004;23:219-28.
20. Krol M, Lankoff A, Buraczewska I, Derezinska E, Wojcik A. Radiation-induced micronucleus frequencies in female peripheral blood lymphocytes collected during the fi rst and second half of the menstrual cycle. Radiat Prot Dosim 2007;123:483-9.
21. Alexandrov VA. Role of the maternal organism in transplacental carcinogenesis. IARC Sci Publ 1983;51:65-79.
22. Fucic A, Markovic D, Ferencic Z, Mildner B, Jazbec AM, Spoljar JB. Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. Environ Mol Mutagen 2005;46:59-63.
23. Fucic A, Markovic D, Herceg Z, Gamulin M, Katic J, Stojkovic R, Ferencic Z, Mildner B, Jazbec AM, Dobranic T. Developmental and transplacental genotoxicology: fluconazole. Mutat Res 2008;657:43-7.
24. Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A, Puskailerova D, Znaor A, Kelecsenyiz, Kurtinaitis J, Rachtan J, Forni A, Vermeulen R, Bonassis. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 2007;165:36-43.
25. Bonassis, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E,Scarfi MR, Zijno A, Norrpa H, Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007;28:625-31.
26. Dusinska M, Collins AR. The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis 2008;23:191-205.
27. Møller P, Möller L, Godschalk RW, Jones GD. Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis 2010;25:109-11.
28. Neri M, Ugolini D, Bonassis, Fucic A, Holland N, Knudsen LE, Sram RJ, Ceppi M, Bocchini V, Merlo DF. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. Mutat Res 2006;612:14-39.
29. Neri M, Fucic A, Knudsen LE, Lando C, Merlo F, Bonassis. Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat Res 2003;544:243-54.
30. Vleminckx C, Klemans W, Schriewer L, Joris I, Lijsen N, Ottogali M, Pays A, Planard C, Rigaux G, Ros Y, Vande Rivière M, Vandenvelde J, De Plaen P, Lakhanisky TH, Maes A, Verschaeve L. Performance of cytogenetic biomarkers on children exposed to environmental pollutants. Toxicolind Health 1997;13:219-30.
31. Autrup H. Transplacental transfer of genotoxins and transplacental carcinogenesis. Environ Health Perspect 1993;101:33-8.
32. Tang D, Warburton D, Tannenbaum SR, Skipper P, Santella RM, Cereijido GS, Crawford FG, Perera FP. Molecular and genetic damage from environmental tobacco smoke in young children. Cancer Epidemiol Biomarkers Prev 1999;8:427-31.
33. Ammenheuser MM, Berenson AB, Stiglich NJ, Whorton EB, Jr., Ward JB, Jr. Elevated frequencies of hprt mutant lymphocytes in cigarette-smoking mothers and their newborns. Mutat Res 1994;304:285-94.
34. Schettgen T, Kutting B, Hornig M, Beckmann MW, Weiss T, Drexler H, Angerer J. Trans-placental exposure of neonates to acrylamide - a pilot study. Int Arch Occup Environ Health 2004;77:213-6.
35. Sampayo-Reyes A, Hernández A, El-Yamani N, López-Campos C, Mayet-Machado E, Rincón-Castañeda CB, Limones-Aguilar Mde L, López-Campos JE, de León MB, González-Hernández S, Hinojosa-Garza D, Marcos R. Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicol Sci 2010;117:63-71.
36. Fucic A, Merlo DF, Ceppi M, Lucas JN. Spontaneous abortions in female populations occupationally exposed to ionizing radiation. Int Arch Occup Environ Health 2008;81:873-9.
37. Alaejos MS, Gonzalez V, Afonso AM. Exposure to heterocyclic aromatic amines from the consumption of cooked red meat and its effect on human cancer risk: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2008;25:2-24.
38. Amrein TM, Andres L, Escher F, Amadò R. Occurrence of acrylamide in selected foods and mitigation options. Food Addit Contam 2007;24:13-25.
39. Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 2001;39:423-36.
40. Kontic-Vucinic O, Sulovic N, Radunovic N. Micronutrients in women's reproductive health: I. Vitamins. Int J Fertil Womens Med 2006;51:106-15.
41. Kontic-Vucinic O, Sulovic N, Radunovic N. Micronutrients in women's reproductive health: II. Minerals and trace elements. Int J Fertil Womens Med 2006;51:116-24.
42. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potentialinhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-90.
43. Nava-Ocampo AA, Velázquez-Armenta Y, Brien JF, Koren G. Elimination kinetics of ethanolin pregnant women. Reprod Toxicol 2004;18:613-7.
44. Wild CP, Montesano R. A model of interaction: afl atoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett 2009;286:22-8.
45. Doi AM, Patterson PE, Gallagher EP. Variability in afl atoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver. Toxicol Appl Pharmacol 2002;181:48-59.
46. Boersma ER, Lanting CI. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation. Adv Exp Med Biol 2000;478:271-87.
47. Karttunen V, Myllynen P, Prochazka G, Pelkonen O, Segerbäck D, Vähäkangas K. Placental transfer and DNA binding of benzo(a)pyrene in human placental perfusion. Toxicol Lett 2010;197:75-81.
48. Diez S, Delgado S, Aguilera I, Astray J, Perez-Gomez B, Torrent M, Sunyer J, Bayona JM. Prenatal and early childhood exposure to mercury and methylmercury in Spain, a high-fish-consumer country. Arch Environ Contam Toxicol 2009;56:615-22.
49. Leck IM, Millar EL. Incidence of malformations since the introduction of thalidomide. Br Med J 1962;2:16-20.
50. van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N. Teratogenic mechanisms of medical drugs. Hum Reprod Update 2010;16:378-94.
51. Włoch S, Pałasz A, Kamiski M. Active and passive transport of drugs in the human placenta. Ginekol Pol 2009;80:772-7.
52. Fucic A SR, Miskov S, Zeljezic D, Markovic D, Gjergja R, Katic J, Jazbec AM, Ivicevic Bakulic T, Demarin V. Transplacental genotoxicity of antiepileptic drugs:animal model and pilot study on mother/newborn cohort. Reprod Toxicol 2010 Oct 16. [Epub ahead of print] doi:10.1016/j.reprotox.2010.08.008
53. Witt KL, Cunningham CK, Patterson KB, Kissling GE, Dertinger SD, Livingston E, Bishop JB. Elevated frequency of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environ Mol Mutagen 2007;48:322-29.
54. Cantor KP. Carcinogens in drinking water: the epidemiologic evidence. Rev Environ Health 2010;25:9-16.
55. Dulout FN, Grillo CA, Seoane AI, Maderna CR, Nilsson R, Vahter M, Darroudi F, Natarajan AT. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 1996;370:151-8.
56. Tsezou A, Kitsiou-Tzelis, Galla A, Gourgiotis D, Papageorgiou J, Mitrou S, Molybdas PA, Sinaniotis C. High nitrate content in drinking water: cytogenetic effects in exposed children. Arch Environ Health 1996;51:458-61.
57. Dávila Rangel JI, López del Rio H, Mireles García F, Quirino Torres LL, Villalba ML, Colmenero Sujo L, Montero Cabrera ME. Radioactivity in bottled waters sold in Mexico. Appl Radiat Isot 2002;56:931-6.
58. 210Po concentrations of bottled mineral waters in Hungary and their committed effective dose. Radiat Prot Dosimetry 2004;108:175-81.
59. Marovic G, Sencar J. Exposure to natural radioactivity from thermal waters in Croatia. Bull Environ Contam Toxicol 2001;67:35-41.
60. rd ed. Vol. 1, Recommendations. Geneva: WHO; 2004.
61. 226Ra in human soft tissue and bone; implications for the ICRP 20 alkaline earth model. Health Phys 1982;42:671-93.
62. 226Ra in Hungarian bottled mineral water. J Environ Radioact 2002;62:235-40.
63. International Commission on Radiological Protection (ICRP). Age dependent doses to members of the public from intake of radionuclides: Part 2 Ingestion dose coefficient. ICRP Publication 67. Ann ICRP 1993;23(3/4).
64. Sichr-Hellert MKF, Manz M. Fifteen years trends in water intake in German children and adolescents: results of the DONALD Study. Acta Paediatr 2001;90:732-7.
65. Rommens C, Ringeard C, Hubert P. Exposure of red bone marrow to ionizing radiation from natural and medical sources in France. J Radiat Prot 2001;21: 209-219.
66. 226Ra and possible consequences. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007;42:817-23.
67. 226Ra from bottled water intake. Health Phys 2005;88:480-5.
68. Tolstykh EI, Kozheurov VP, Vyushkova OV, Degteva MO. Analysis of strontium metabolism in humans on the basis of the Techa river data. Radiat Environ Biophys 1997;36:25-9.
69. Bauchinger M, Salassidis K, Braselmann H, Vozilova A, Pressl S, Stephan G, Snigiryova G, Kozheurov VP, Akleyev A. FISH-based analysis of stable translocations in a Techa River population. Int J Radiat Biol 1998;73:605-12.
70. Dobiás L, Hanzl J, Rössner P, Jana L, Rulísková H, Andlová S, Klementová H. [Evaluation of the clastogenic effect of formaldehyde in children in preschool and school facilities, in Czech]. Cesk Hyg 1988;33:596-604.
71. Srb V, Rossner P, Zudova Z. [Action of formaldehyde and toluene on selected cytogenetic indicators in apprentices, in Czech]. Cesk Hyg 1990;49:66-75. (Pubitemid 20134363)
72. Pluth JM, Ramsey MJ, Tucker JD. Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat Res 2000;465:101-11.
73. Hansen C, Asmussen I, Autrup H. Detection of carcinogen-DNA adducts in human fetal tissues by the 32P-postlabeling procedure. Environ Health Perspect 1993;99:229-31.
74. Henson MC, Piasek M, Chedrese PJ, Castracane VD. Metal toxicity in mammalian reproduction. In: Eldridge JC, Stevens JT, editors. Endocrine Toxicology - Target Organ Toxicology Series. New York-London: Informa Healthcare Publishers; 2010. p. 256-79.
75. Godschalk R, Hogervorst J, Albering H, Mercelina-Roumans P, van Schooten FJ, de Haan J, Kleinjans J. Interaction between cadmium and aromatic DNA adducts in hprt mutagenesis during foetal development. Mutagenesis 2005;20:181-5.
76. Bilban M, Vaupoti J. Chromosome aberrations study of pupils in high radon level elementary school. Health Phys 2001;80:157-63.
77. Srám RJ, Podrazilová K, Dejmek J, Mracková G, Pilcík T. Single cell gel electrophoresis assay: sensitivity of peripheral white blood cells in human population studies. Mutagenesis 1998;13:99-103.
78. Stoulos S, Manolopoulou M, Papastefanou C. Assessment of natural radiation exposure and radon exhalation from building materials in Greece. J Environ Radioact 2003;69:225-40.
79. Perera FP, Jedrychowski W, Rauh V, Whyatt RM. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 1999;107:451-60.
80. Calderon-Garciduenas L, Wen-Wang L, Zhang YJ, Rodriguez-Alcaraz A, Osnaya N, Villarreal-Calderon A,Santella RM. 8-hydroxy-2'-deoxyguanosine, a major mutagenic oxidative DNA lesion, and DNA strand breaks in nasal respiratory epithelium of children exposed to urban pollution. Environ Health Perspect 1999;107:469-74.
81. Pedersen M, Wichmann J, Autrup H, Dang DA, Decordier I, Hvidberg M, Bossi R, Jakobsen J, Loft S, Knudsen LE. Increased micronuclei and bulky DNA adducts in cord blood after maternal exposures to traffic-related air pollution. Environ Res 2009;109:1012-20.
82. Yáñez L, García-Nieto E, Rojas E, Carrizales L, Mejía J, Calderón J, Razo I, Díaz-Barriga F. DNA damage in blood cells from children exposed to arsenic and lead in a mining area. Environ Res 2003;93:231-40.
83. Druzhinin VG, Lifanov AYu, Rytenkov VYu. Cytogenetic abnormalities revealed in adolescents from Kamerovskaya oblast as indicators of adverse ecological conditions in the region. Genetica 1997;33:699-703.
84. Stepanova EI, Vanyhina EA. Clinical and cytogenetical characteristic of children born by subjects recovered of severe radiation disease I and IIlevel as a result of Chernobyl. Tsitologiia Genetika 1993;27:10-3.
85. Weinberg ABK, Kirzhner VM, Avivi A, Fahima T, Nevo E, Shapiro S, Rennert G, Piatak O, Stepanova EI, Skvaskaja E. Very high mutation rate in offspring of Chernobyl accident liquidators. Proc R Soc Lond 2001;268:1001-05.
86. Roman E, Beral V, Carpenter L, Watson A, Barton C, Ryder H, Aston DL. Childhood leukaemia in the West Berkshire and Basingstoke and North Hampshire District Health Authorities in relation to nuclear establishments in the vicinity. Br Med J (Clin Res Ed) 1987;294:597-602.
87. Goldsmith JR. Nuclear installations and childhood cancer in the UK: mortality and incidence for 0-9-year-old children, 1971-1980. Sci Total Environ 1992;127:13-35.
88. Gardner MJ. Father's occupational exposure to radiation and the raised level of childhood leukemia near the Sellafield nuclear plant. Environ Health Perspect 1991;94:5-7.
89. Körblein A, Hoffman W. Childhood cancer in the vicinity of German nuclear power plant. Med Glob Surviv 1999;6:18-23.
90. Parker L, Pearce MS, Dickinson HO, Aitkin M, Craft AW. Stillbirths among offspring of male radiation workers at Sellafield nuclear reprocessing plant. Lancet 1999;354:1407-14.
91. Schmitz-Feuerhake I, Dannheim B, Heimers A, Oberheitmann B,Schröder H, Ziggel H. Leukemia in the proximity of a German boiling-water nuclear reactor: evidence of population exposure by chromosome studies and environmental radioactivity. Environ Health Perspect 1997;105:1499-504.
92. Mangano SJ, Cang C. Elevated childhood cancer incidence proximate to US nuclear power plants. Arch Environ Health 2003;58:74-82.
93. Ron E. Cancer risks from medical radiation. Health Phys 2003;85:47-59.
94. Kleinerman RA. Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol 2006;36:121-5.
95. Doody M, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE. Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine 2000;25:2052-63.
96. Carpenter DO. Electromagnetic fields and cancer: the cost of doing nothing. Rev Environ Health 2010;25:75-80.
97. Repacholi MH. Health risks from the use of mobile phones. Toxicol Lett 2001;120:323-31.
98. Orendacova J, Orendac M, Racekova E, Marsala J. Neurobiological effects of microwave exposure: a review focused on morphological findings in experimental animals. Arch Ital Biol 2007;145:1-12.
99. Hardell L, Carlberg M. Mobile phones, cordless phones and the risk for brain tumours. Int J Oncol 2009;35:5-17.
100. The INTERPHONE study group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol 2010;39:675-94.
101. Schüz J. Mobile phone use and exposures in children. Bioelectromagnetics 2005;S7:S45-50.
102. Scheuplein R, Charnley G, Dourson M. Differential sensitivity of children and adults to chemical toxicity. I. Biological basis. Regul Toxicol Pharmacol 2002;35:429-47.
103. Hines RN, McCarver DG. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 2002;300:355-60.
104. Ginsberg G, Hattis D, Miller R, Sonawane B. Pediatric pharmacokinetic data: implications for environmental risk assessment for children. Pediatrics 2004;113:973-83.
105. Stasenko S, Bradford EM, Piasek M, Henson MC, Varnai VM, Jurasovic J, Kusec V. Metals in human placenta: focus on the effects of cadmium on steroid hormones and leptin. J Appl Toxicol 2010;30:242-53.
106. Greim HA. The endocrine and reproductive system: adverse effects of hormonally active substances. Pediatrics 2004;113:1070-5.
107. Koppe JG, Bartonova A, Bolte G, Bistrup ML, Busby C, Butter M, Dorfman P, Fucic A, Gee D, van den Hazel P, Howard V, Kohlhuber M, Leijs M, Lundqvist C, Moshammer H, Naginiene R, Nicolopoulou-Stamati P, Ronchetti R, Salines G, Schoeters G, ten Tusscher G, Wallis MK, Zuurbier M. Exposure to multiple environmental agents and their effect. Acta Paediatr Suppl 2006;95:106-13.
108. Barabasi AL, OltvaizN. Network biology: Understanding the cell functional organization, Nature Reviews Genetics 2004;5:101-113.
109. Andersen ME, Yang RS, French CT, Chubb LS, Dennison JE. Molecular circuits, biological switches, and nonlinear dose-response relationships. Environ Health Perspect 2002;110:971-8.
110. Streffer C. Bystander effects, adaptive response and genomic instability induced by prenatalirradiation. Mutat Res 2004;568:79-87.
111. Roy D, Liehr JG. Estrogen, DNA damage and mutations. Mutat Res 1999;424:107-15.
112. Pogribny I, Raiche J, Slovack M, Kovalchuk O. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem Biophys Res Commun 2004;320:1253-61.